Spasticity is an inadequately acknowledged but extremely common symptom related to MS. It is estimated that as many as 85 percent of people with MS experience spasticity to some degree.

Spasticity can be a debilitating symptom with a negative impact on a person’s participation in family life, work, social interactions and intimate relations. It may also affect a person’s autonomy and self-image. Ineffectively treated spasticity can have serious, long-term complications and may also make other symptoms more difficult to manage.

Given the far-reaching consequences, timely evaluation and treatment by clinical professionals with specific knowledge of spasticity is crucial. A comprehensive assessment of spasticity includes not only an evaluation of the physical changes associated with the symptom, but also requires an understanding of a person’s lifestyle, coping strategies, expectations and personal goals.

Pharmacological and other treatment options for spasticity can be effective for many people. On the other hand, some medications cause adverse effects that preclude their use in others. When oral medications do not achieve successful spasticity management, other possible strategies, such as surgery, may need to be considered. Fortunately there are different options available which can be evaluated by the person with MS, their family and the healthcare team together.

An important theme in this issue of MS in focus is the interdisciplinary approach to the evaluation, goal-setting and treatment of spasticity. The contributors are from a variety of professional backgrounds including nursing, medicine, rehabilitation and research. This combination of expertise provides a comprehensive view of spasticity in a language that is accessible to healthcare professionals and people with MS alike.
I look forward to receiving your comments.

Michele Messmer Uccelli, Editor